ICPT/ fda and new obstacle for Nash | CYDY Message Board Posts


CytoDyn Inc.

  CYDY website

  • Please accept my sincerest apologies for failing to publicly acknowledge our fallen heroes this past Memorial Day. No excuse I could offer could justify the oversight. Along with you, I salute the many men and women who have proudly and selflessly served in our military to protect, defend and secure the freedoms and liberties we enjoy each and every day. Their bravery in making the ultimate sacrifice will forever be appreciated and they will always be remembered and celebrated and never taken for granted or forgotten.


CYDY   /  Message Board  /  Read Message

 
BOARD

GROUPS
 










Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message board, top of board
Msg  14699 of 14733  at  3/22/2023 3:03:06 PM  by

Bluemoon

The following message was updated on 3/22/2023 3:08:40 PM.

ICPT/ fda and new obstacle for Nash

  We also expect this advisory committee will have important implications for other NASH drug developers, as it represents the first detailed insight into the FDA's process for reviewing NASH drug applications more broadly," he said in a report.
  
https://www.investors.com/news/technology/icpt-stock-tumbles-on-new-obstacle-for-its-nash-drug/  


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 4  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message board, top of board




Financial Market Data provided by
.
Loading...